Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Sorrento Therpt (NQ: SRNE )

10.50 USD +1.07 (+11.35%)
Streaming Delayed Price Updated: 5:47 AM EST, Jan 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Sorrento Therpt

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Personalized Stem Cells Announces Licensing Agreement for its Allogeneic Stem Cell Program Including COVID-19 Therapy
Tags science banking/finance/investment s:california
From EIN Presswire
Sorrento Adds Mesenchymal Stem Cell Program (MSC) That Has Been Cleared for a Phase 1 Trial by the FDA to the Pipeline of COVID-19 Focused Rescue Therapies
From GlobeNewswire News Releases
Sorrento COVID-19 R&D October 13, 2020 Pipeline Call Details Released
From GlobeNewswire News Releases
Thinking about buying stock in Gevo Inc, Intec Pharma, Advanced Micro Devices, Norwegian Cruise Line, or Sorrento Therapeutics?
InvestorsObserver issues critical PriceWatch Alerts for GEVO, NTEC, AMD, NCLH, and SRNE. 
From PR Newswire
Sorrento Announces the Discovery of Salicyn-30 Small Molecule That Strongly Inhibits SARS-CoV-2 Infection in Preclinical Studies and Highlights its Place in a Potential Multi-Modal Therapy Strategy in
From GlobeNewswire News Releases
Scilex Holding Company, a Subsidiary of Sorrento Therapeutics, Announces Continuous Sales Growth in ZTlido® and Expects to Complete Enrollment on its SP-102 (SEMDEXA™) Phase 3 Pivotal Trial Program in
From GlobeNewswire News Releases
Sorrento to Host a R&D Day to Showcase COVID-19 Product Pipeline
From GlobeNewswire News Releases
Thinking about buying stock in Co-Diagnostics, Janus Henderson Group, Sorrento Therapeutics, Inovio Pharmaceuticals, or American Airlines?
InvestorsObserver issues critical PriceWatch Alerts for CODX, JHG, SRNE, INO, and AAL. 
From PR Newswire
Thinking about buying stock in Iterum Therapeutics, FuelCell Energy, Allena Pharmaceuticals, General Electric, or Sorrento Therapeutics?
InvestorsObserver issues critical PriceWatch Alerts for ITRM, FCEL, ALNA, GE, and SRNE. 
From PR Newswire
SORRENTO THERAPEUTICS AND VIRALCLEAR ENTER INTO AGREEMENT TO EXPLORE THE COMBINATION OF ANTIBODY AND ANTIVIRAL ASSETS AGAINST COVID-19
From GlobeNewswire News Releases
Sorrento Therapeutics and ViralClear Enter Into Agreement to Explore Combination Antibody Plus Antiviral Therapy Against COVID-19
From GlobeNewswire News Releases
Thinking about buying stock in Sorrento Therapeutics, New Age Beverages, FuelCell Energy, Sunworks, or Inovio Pharmaceuticals?
InvestorsObserver issues critical PriceWatch Alerts for SRNE, NBEV, FCEL, SUNW, and INO. 
From PR Newswire
Sorrento Releases Preclinical Data for STI-1499 (COVI-Guard™) and STI-2020 (COVI-AMG™), Potent Neutralizing Antibodies Against SARS-CoV-2
From GlobeNewswire News Releases
Sorrento Releases Positive Results of Phase 1B Trial of Resiniferatoxin (RTX) In Reduction of OsteoArthritis (OA) Knee Pain
From GlobeNewswire News Releases
Sorrento Therapeutics, Inc. (NASDAQ:SRNE) Long Term Investor Alert: Investigation of Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 09/25/2020 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Sorrento Therapeutics, Inc.. 
From SBWire - Latest Press Releases
Sorrento Therapeutics Releases Positive Results of Phase 1B Trial of Resiniferatoxin (RTX) Epidural in Cancer Patients with Reported Intractable Pain
From GlobeNewswire News Releases
Thinking about buying stock in Sorrento Therapeutics, Herman Miller, iBio Inc, TOP Ships, or Aurora Cannabis?
InvestorsObserver issues critical PriceWatch Alerts for SRNE, MLHR, IBIO, TOPS, and ACB. 
From PR Newswire
Sorrento Receives US FDA Clearance to Proceed With Phase 1 Clinical Trial of STI-1499 (COVI-GUARD) Neutralizing Antibody in COVID-19 Positive Patients
From GlobeNewswire News Releases
Thinking about buying stock in Novus Therapeutics, Delta Air Lines, Sorrento Therapeutics, Carnival Corp, or Exela Technologies?
InvestorsObserver issues critical PriceWatch Alerts for NVUS, DAL, SRNE, CCL, and XELA. 
From PR Newswire
Why Psychedelic Medicine Startups Are Poised To Get A Share Of Next Billion Dollar Market
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Why Psychedelic Medicine Startups Are Poised To Get A Share Of Next Billion Dollar Market
Financialnewsmedia.com News Commentary 
From PR Newswire
Vcinity Welcomes Seasoned Business Leader, Dr. Robin L. Smith, to Its Board of Directors
Vcinity, Inc., a company empowering the edge and redefining cloud, today announced that Robin L. Smith, MD, MBA – a business leader, entrepreneur, medical doctor and philanthropist – joined its Board... 
From Business Wire News Releases
Thinking about buying stock in Cassava Sciences, Mersana Therapeutics, Sorrento Therapeutics, Dynavax Technologies, or Co-Diagnostics?
InvestorsObserver issues critical PriceWatch Alerts for SAVA, MRSN, SRNE, DVAX, and CODX. 
From PR Newswire
Sorrento Secures Exclusive License From Mayo Clinic for Antibody-Drug-Nanoparticle Albumin-Bound Immune Complex (ADNIC) Platform
From GlobeNewswire News Releases
Thinking about buying stock in CleanSpark, Atara Biotherapeutics, FuelCell Energy, Sorrento Therapeutics, or Plug Power?
InvestorsObserver issues critical PriceWatch Alerts for CLSK, ATRA, FCEL, SRNE, and PLUG. 
From PR Newswire
Thinking about buying stock in iBio Inc, Virgin Galactic, Sorrento Therapeutics, Adamis Pharmaceuticals, or Plug Power?
InvestorsObserver issues critical PriceWatch Alerts for IBIO, SPCE, SRNE, ADMP, and PLUG. 
From PR Newswire
Most Popular Robinhood Stocks: $SNE $SRNE $LUV
Tags The Market Signal
From The Market Signal
Thinking about buying stock in ADMA Biologics, Fluidigm Corp, Boxlight Corp, Sorrento Therapeutics, or United Airlines?
InvestorsObserver issues critical PriceWatch Alerts for ADMA, FLDM, BOXL, SRNE, and UAL. 
From PR Newswire
Sorrento Announces the Closing of Its Acquisition of SmartPharm to Build Next Generation G-MAB-Encoded Plasmid DNA For Cost-Efficient and In Vivo Production of Antibody Therapeutics in Patients
From GlobeNewswire News Releases
Are COVID-19 Vaccines And Therapeutics Advancing Faster Than Expected
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.